Gefitinib 250 mg/1

Gefitinib 250 mg tablets are a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins that contribute to cancer cell growth.

Gefitinib is primarily used in the treatment of certain types of non-small cell lung cancer. It works by targeting and blocking proteins that help cancer cells grow and spread. This medication is often prescribed for patients with specific genetic mutations that make their cancer cells more responsive to Gefitinib. It is important to consult a healthcare provider to determine if Gefitinib is suitable for your condition.

Common effects of Gefitinib may include skin rash, diarrhea, and dry skin. Some patients may also experience nausea, loss of appetite, and fatigue. These effects vary among individuals and may not affect everyone who takes the medication.

Gefitinib should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. Inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Gefitinib may interact with certain medications, including those that are metabolized by the liver. It is important to discuss all current medications with your healthcare provider before starting Gefitinib. Avoiding alcohol and certain foods that may affect liver function is also advisable.